Patents Assigned to ECI PHARMACEUTICALS, LLC
  • Oral liquid compositions comprising amlodipine besylate and methods of using the same
    Patent number: 11452690
    Abstract: The present disclosure provides oral liquid compositions comprising amlodipine besylate with favorable solubility and stability. Also provided herein are methods of using the oral liquid compositions.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: September 27, 2022
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventors: Nirali R. Bhatt, Alok Kapadia
  • Oral liquid compositions including valsartan
    Patent number: 11446243
    Abstract: The present disclosure provides an oral liquid composition comprising valsartan with enhanced solubility and stability. Also, provided herein are methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: July 3, 2020
    Date of Patent: September 20, 2022
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventor: Nirali R. Bhatt
  • Oral liquid compositions including valsartan
    Patent number: 11413275
    Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: August 16, 2022
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventors: Greg Thomas, Joseph Michael Esposito
  • Pharmaceutical compositions including hydrocodone bitartrate and guaifenesin
    Patent number: 11202766
    Abstract: Novel hydrocodone bitartrate and guaifenesin pharmaceutical compositions. Methods of making and using the hydrocodone bitartrate and guaifenesin pharmaceutical compositions also are disclosed.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: December 21, 2021
    Assignee: ECI Pharmaceuticals, LLC
    Inventors: Solomon Goll, Nirali R. Bhatt
  • Oral liquid compositions including valsartan
    Patent number: 10973802
    Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 13, 2021
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventor: Greg Thomas
  • Pharmaceutical compositions including carvedilol and methods of using the same
    Patent number: 10959985
    Abstract: The present disclosure provides oral liquid compositions including carvedilol with enhanced solubility and stability. Also provided herein are methods of using oral liquid compositions for the treatment of hypertension, treatment of heart failure, and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: March 30, 2021
    Assignee: ECI Pharmaceuticals, LLC
    Inventors: Nirali R. Bhatt, Solomon Goll
  • Pharmaceutical compositions including carvedilol and methods of using the same
    Patent number: 10772869
    Abstract: The present disclosure provides oral liquid compositions including carvedilol with enhanced solubility and stability. Also provided herein are methods of using oral liquid compositions for the treatment of hypertension, treatment of heart failure, and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: September 15, 2020
    Assignee: ECI Pharmaceuticals, LLC
    Inventors: Nirali R. Bhatt, Solomon Goll
  • Oral liquid compositions including valsartan
    Patent number: 10548838
    Abstract: The present disclosure provides an oral liquid composition comprising valsartan with enhanced solubility and stability. Also, provided herein are methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: February 4, 2020
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventor: Greg Thomas
  • Oral liquid compositions including valsartan
    Patent number: 10478422
    Abstract: An aspect of the present disclosure is directed to an oral liquid composition comprising valsartan with enhanced solubility and stability. Other aspects are directed to methods of using the oral liquid compositions for the treatment of hypertension, treatment of heart failure and reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: November 19, 2019
    Assignee: ECI PHARMACEUTICALS, LLC
    Inventor: Greg Thomas